Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy

1 more authors
  1. 1HCW Biologics Inc. Miramar, FL, USA
  2. 2HCW Biologics Inc., Miramar, FL, USA

Related

  1. Bispecific VSV-G Engagers: A Platform for Cell-Type-Specific Delivery of Viral Vectors
    G. N. Nenavath, D. Gataulin, M. Eisenstein +15
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  2. T-cell engagers in solid tumors: challenges and emerging strategies
    Jose Forero, Ruchi Jani, Xena Zheng +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  3. Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis
    Zhenfen Ling, Xia Liu, Wensi Li +19
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. 902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
    Carsten Müller-Tidow, Hartmut Goldschmidt, Hermann Einsele +16
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  5. CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy
    Xue Lei, Weilan Liu, Zongnian Luo +3
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyOncologyPLOS
BibTeX
@article{zhu2026innovative,
  title = {{627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy}},
  author = {Xiaoyun Zhu and Lijing You and Varghese George and Niraj Shrestha and Hamidreza Farzaneh and Crystal Gilkes and Natalia Valderrama and Alyssa Thompson and Lucas Gomez and Christian Echeverri and Peter R Rhode and Jack O Egan and Hing C Wong},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0627},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0627},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 627 An innovative approach to improve bispecific T-cell engagers for solid tumor therapy
AU  - Xiaoyun Zhu
AU  - Lijing You
AU  - Varghese George
AU  - Niraj Shrestha
AU  - Hamidreza Farzaneh
AU  - Crystal Gilkes
AU  - Natalia Valderrama
AU  - Alyssa Thompson
AU  - Lucas Gomez
AU  - Christian Echeverri
AU  - Peter R Rhode
AU  - Jack O Egan
AU  - Hing C Wong
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0627
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0627
SN  - 2051-1426
ER  -